Gene and Cell Therapy – Products

TQ Therapeutics acquires Juno Therapeutics GmbH, expanding its cell therapy platform and access to key intellectual property.

Amsbio expands antibody portfolio with new markers for precise stem cell research and quality assurance.

Telesis Bio and Regeneron collaborate to deploy the Gibson SOLA™ platform, enabling faster, automated gene synthesis to accelerate drug discovery.

CytoPak single-use bags support closed-system CGT manufacturing with weldable tubing, ready-to-use format, and optimized cytokine dosing—ensuring sterility, consistency, and scalability from research to commercial production.

Waters Corporation has acquired Halo Labs, a specialist in imaging technologies for detecting and analyzing particles in therapeutic products, including cell, protein, and gene therapies.

Aptamer Group presented new data on its Optimer therapeutic delivery vehicle for liver fibrosis, showing its potential for broad applicability in fibrotic diseases at the ASGCT 2025 Annual Meeting.

Circio Holding ASA (OSE: CRNA), announces the presentation of new and strengthened in vivo data at the American Society of Gene and Cell Therapy (ASGCT) annual meeting 2025 in New Orleans, USA.

This app note highlights a novel picodroplet-based platform that provides rapid, high-throughput assessment of cell product fitness, offering a valuable tool for both QC release and early-stage research.

RoosterBio and Thermo Fisher partner to streamline cell and exosome therapy development and manufacturing.

Atelerix partners with MineBio to bring its pioneering hydrogel-based cell preservation technology to China, enhancing biotech logistics and reducing costs.